结核病若干问题研究进展

中国防痨杂志 ›› 2011, Vol. 33 ›› Issue (9): 611-614.

结核病若干问题研究进展

成诗明庄玉辉

中国疾病预防控制中心结核病预防控制中心（成诗明）；解放军第三O九医院结核病研究所（庄玉辉）

收稿日期:2011-06-12 出版日期:2011-09-10 发布日期:2012-01-29

Research progress of several tuberculosis related issues

CHENG Shi-ming，ZHUANG Yu-hui

Received:2011-06-12 Online:2011-09-10 Published:2012-01-29

摘要/Abstract

成诗明庄玉辉. 结核病若干问题研究进展[J]. 中国防痨杂志, 2011, 33(9): 611-614.

CHENG Shi-ming，ZHUANG Yu-hui. Research progress of several tuberculosis related issues[J]. Chinese Journal of Antituberculosis, 2011, 33(9): 611-614.

［1］World Health Organization.Global tuberculosis control report 2010（WHO/HTM/TB/2010.7）. Geneva：World Health Organization, 2010.
［2］Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature,1998,393(6685):537-544.
［3］刘洁，万康林. 结核分枝杆菌基因组学和后基因组学研究进展. 中国人兽共患病学报,2007,23(4):398-400.
［4］Sreevatsan S, Pan X, Stockbauer KE, et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A,1997,94(18):9869-9874.
［5］熊志红，庄玉辉，李国利. 差显技术分析结核杆菌H37Rv与H37Ra差异表达的基因. 微生物学通报,2005,32(3):57-61.
［6］Brosch R, Gordon SV, Buchrieser C, et al. Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur. Yeast,2000,17(2):111-123.
［7］庄玉辉.结核分支杆菌基因组后时代的展望. 中华结核和呼吸杂志,2001,24(7):391-393.
［8］王陇德. 结核病防治.北京：中国协和医科大学出版社,2004.
［9］Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet,1997,349(9063):1436-1442.
［10］邵凌云，翁心华，胡忠义，等. 中国汉族人群结核易感相关基因多态性研究. 中华传染病杂志,2004,22(5):302-305.
［11］刘玮，张翠英，吴晓明，等. 维生素D受体基因多态性与肺结核易感性的病例对照研究. 中华流行病学杂志,2003,24(5):389-391.
［12］刘志辉，罗一鲁，周琳，等. HLADR基因与中国南方汉族部分人群肺结核易感基因的研究. 中华结核和呼吸杂志,2004,27(6):390-393.
［13］刘玮，张芳，赵秋敏，等. 甘露糖结合凝集素基因多态性与肺结核易感性的研究. 中国热带医学,2006,6(3):387-389.
［14］Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol,1993,22(6):1154-1158.
［15］Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics,1995,96(1 Pt 1):29-35.
［16］季敏，章建康. 遏制结核病全球合作伙伴组织及新型结核病疫苗研发现状和方向. 国际生物制品学杂志,2011,34(2):97-103.
［17］Aagaard C, Hoang T, Dietrich J, et al. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med,2011,17(2):189-194.
［18］吴小林. 结核病药物研发的进展、挑战和展望. 国外医药抗生素分册,2010,31(3):119-122.
［19］康晓宇，高永清. 临床开发中的新型抗结核药物. 国际药学研究杂志,2009,36(3):230-233.
［20］Steingart KR, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis,2006,6(9):570-581.
［21］熊礼宽，杨应周，黄袆，等. 一种新型快速检出分枝杆菌变色液体培养基的评价. 中华检验医学杂志,2001,24(1):49.
［22］Abebe F, HolmHansen C, Wiker HG, et al. Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand J Immunol,2007,66(2-3):176-191.
［23］World Health Orangnization. WHO endorses new rapid tuberculosis test［EB/OL］. ［2010-12-08］. http:∥www.who.int/mediacentre/news/releases/2010/tb_test_20101208/en/index.html
［24］Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med,2010,363(11):1005-1015.